KIF20A and pancreatic neoplasm: KIF20A is overexpressed and represents a potential immunotherapeutic target in pancreatic cancer, and silencing KIF20A using a small interfering RNA inhibited the proliferation, motility and invasion of pancreatic cancer cell lines [23].